InsidersTradesSigma
Track the Calliditas Therapeutics AB stock price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. The latest transaction was disclosed on 3 March 2021 (Purchase). Among the most active insiders: Katayoun Welin-Berger. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Calliditas Therapeutics AB is a biopharmaceutical company focused on developing treatments for rare kidney diseases. It is listed on the XSTO stock exchange.